Temozolomide

Other Notes Please note that Sigma-Aldrich provides this product to early discovery researchers as part of a collection of rare and unique chemicals. Sigma-Aldrich does not collect analytical data for this product.

S-(TRIPHENYLSILYL)THIOBENZOATE-

Teclozan (WIN 13146) is an antiprotozoal agent, class in benzylamine derivatives. Teclozan intervenes in the phospholipid metabolism preventes the formation of arachidonic acid. Teclozan acts in the intestinal lumen being effective in Anti- G.

Teclozan (WIN 13146) is an antiprotozoal agent, class in benzylamine derivatives. Teclozan intervenes in the phospholipid metabolism preventes the formation of arachidonic acid. Teclozan acts in the intestinal lumen being effective in Anti- G.

Teclozan (WIN 13146) is an antiprotozoal agent, class in benzylamine derivatives. Teclozan intervenes in the phospholipid metabolism preventes the formation of arachidonic acid. Teclozan acts in the intestinal lumen being effective in Anti- G.

Teclozan (WIN 13146) is an antiprotozoal agent, class in benzylamine derivatives. Teclozan intervenes in the phospholipid metabolism preventes the formation of arachidonic acid. Teclozan acts in the intestinal lumen being effective in Anti- G.

Application Temozolomide has been used for analyzing drug resistance mechanisms in glioblastoma cell lines 15,16 . Biochem/physiol Actions Temozolomide is a DNA methylating agent and drug resistance-modifying agent: anti-tumor and

Application Temozolomide has been used for analyzing drug resistance mechanisms in glioblastoma cell lines 15,16 . Biochem/physiol Actions Temozolomide is a DNA methylating agent and drug resistance-modifying agent: anti-tumor and

General description Certified pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to pharmacopeia primary standards. Temozolomide is

A cell-permeable, orally bioavailable, blood-brain barrier-permeant MTIC [5-(3-methyltriazen-1-yl-)-imidazole-4-carboxamide] prodrug whose in vivo DNA alkylating activity is employed in anticancer therapy. MGMT ( O 6 -methylguanine DNA methyl

An imidazotetrazine that is converted to a compound capable of alkylating DNA, thus interfering with DNA replication and leading to cytotoxicity in proliferating cells rapidly and completely absorbed from the gastrointestinal tract after oral

CAS: 33725-74-5 EC No: 251-658-2 MDL No: MFCD00012035 UN No: UN3131 Haz Class: 4.3 (8) Packing Group: II Crystalline Molecular Formula: C₁₆H₄₀BN MW: 257.31 Melting Point: 124-128&deg Flash Point: 140&degC (284&degF)